Eastern equine encephalitis is a rare but deadly mosquito-borne disease that kills about half of the people it infects. However, research by a team of scientists at UTMB, the University of Pittsburgh Center for Vaccine Research and the Weizmann Institute of Science has discovered that the EEEV uses a never-before-documented mechanism to “hijack” one of the cellular regulatory systems of its hosts to suppress immunity holds promise for better outcomes. The discovery, which will be published in the journal Nature and is funded by the National Institutes of Health, could aid in the development of vaccines and treatments for EEEV, which in the United States is found primarily in the Atlantic and Gulf States. It also may be useful in efforts to inhibit other diseases, such as West Nile virus, dengue fever, rhinovirus and SARS.